source
- FDA approves Orzeyful, first drug to treat all symptoms of narcolepsy type 1The U.S. Food and Drug Administration announced on August 5, 2026 that it has approved Orzeyful (oveporexton) tablets for adults with narcolepsy type 1. Orzeyful is the first therapy cleared to tr…
- Emergent BioSolutions cuts 93 jobs and eliminates chief medical officer role in new restructuring planEmergent BioSolutions announced a new round of restructuring aimed at aligning the company with current business realities, disclosed alongside its second‑quarter earnings. The plan includes layin…